Recall due to incorrect labelling

These tests for self-testing for the detection of sexually transmitted diseases (STDs) from the manufacturer Genesign Biotech (XIAMEN) Co, Ltd are also marketed under the brand name JAL Medical (Singapore) Pte. Ltd. These products do not bear a CE mark, which means that they do not fulfil the requirements for in-vitro diagnostics. The BASG has information that the manufacturer has not carried out the required EU conformity assessment procedure. These products are therefore not marketable on the EU market.

The donor/the donor gametes have been permanently blocked.

Recall due to deactivated serial numbers

The Federal Office for Safety in Health Care (BASG) has been informed by the ECDC (European Centre for Disease Prevention and Control) that confirmed autochthonous dengue cases have been recorded in oversea departments of France.

The Federal Office for Safety in Health Care (BASG) has been informed by the ECDC (European Centre for Disease Prevention and Control) that confirmed autochthonous cases of chikungunya have been recorded in oversea departments of France.

The Federal Office for Safety in Health Care (BASG) warns of a counterfeit medical device that could be mistaken for the legitimate product "Needleless Airtight Infusion Connector Protector" from the manufacturer "Zhejiang Runqiang Medical Instruments Co., Ltd.".

The new medicines information system of the Federal Office for Safety in Health Care (BASG) will go live on 10 February 2026. The previous information from the "Medicinal product index", the "Shortages index", the"Export ban index", the "BASG announcements" and the "BASG votes" will be merged into a compact medicines information portal at medikamente.basg.gv.at.

Aktuelles aus dem Meeting vom 26.01.-29.01.2026 zu Neuzulassungen, Indikationserweiterungen, neu veröffentlichten EPAR's und kürzlich gestarteten Verfahren.

The donor/the donor gametes have been blocked.